Table 2.
The Analysis of Improvement of renal damage indices.
| Renal damage indices and comparison between the groups | No. of studies | WMD [95% CI] | P value |
|---|---|---|---|
| β 2-MG | |||
| Astragalus versus glucose injection [10] | 1 | −15.14 [−21.61, −8.67] | P < 0.00001 |
| mAlb | |||
| Astragalus versus glucose injection [10] | 1 | −28.4 [−47.67, −9.15] | P = 0.004 |
| Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11] | 1 | −4.20 [−7.47, −0.93] | P = 0.01 |
| eGFR | |||
| Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11] | 1 | 4.10 [−2.38, 10.58] | P = 0.21 |
| pulse pressure | |||
| Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11] | 1 | −7.00 [−11.56, −2.44] | P = 0.003 |
| SBP | |||
| Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11] | 1 | −21.70 [−31.24, −12.16] | P < 0.00001 |
| DBP | |||
| Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11] | 1 | −4.20 [−11.02, 2.62] | P = 0.23 |
| serum potassium | |||
| Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11] | 1 | −0.08[−0.28, 0.12] | P = 0.44 |
| twenty-four hours urinary protein content | |||
| Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11] | 1 | −0.05 [−0.07, −0.04] | P < 0.00001 |
| Astragalus plus Lotensin, Plendil versus Lotensin, and Plendil [13] | 1 | −0.21 [−0.50, 0.08] | P = 0.15 |
| BUN | |||
| Astragalus versus prostaglandin [12] | 1 | −7.39 [−9.83, −4.95] | P < 0.00001 |
| Scr | |||
| Astragalus versus prostaglandin [12] | 1 | −3.37 [46.05, 39.31] | P = 0.88 |
| Ccr | |||
| Astragalus versus prostaglandin [12] | 1 | 6.84 [4.57, 9.11] | P < 0.00001 |